Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE)
2015-002657-36Phase 3Unknown
- Sponsor
- University of Newcastle
- Start
- Oct 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in ischemic stroke comparing Tenecteplase with Alteplase (2 arms). Primary endpoint: Modified Rankin Scale 0–1 at 3 months. Status: unknown.
02
Drugs
tenecteplasetissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2015-002657-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002657-36.